Kiniksa Pharmaceuticals International Plc (NASDAQ: KNSA) is -5.71% lower on its value in year-to-date trading and has touched a low of $16.56 and a high of $28.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KNSA stock was last observed hovering at around $19.90 in the last trading session, with the day’s loss setting it -1.25%.
Currently trading at $18.65, the stock is -15.33% and -10.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.26 million and changing -6.28% at the moment leaves the stock -16.99% off its SMA200. KNSA registered 5.19% gain for a year compared to 6-month loss of -23.78%. The firm has a 50-day simple moving average (SMA 50) of $20.939 and a 200-day simple moving average (SMA200) of $22.467825.
The stock witnessed a -17.11% gain in the last 1 month and extending the period to 3 months gives it a -8.13%, and is -14.29% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.06% over the week and 4.51% over the month.
Kiniksa Pharmaceuticals International Plc (KNSA) has around 315 employees, a market worth around $1.35B and $423.24M in sales. Fwd P/E is 15.09. Profit margin for the company is -10.21%. Distance from 52-week low is 12.62% and -33.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-9.68%).
with sales reaching $132.22M over the same period.The EPS is expected to grow by 212.29% this year, but quarterly earnings will post 38.01% year-over-year. Quarterly sales are estimated to grow 65.57% in year-over-year returns.
240.0 institutions hold shares in Kiniksa Pharmaceuticals International Plc (KNSA), with institutional investors hold 93.67% of the company’s shares. The shares outstanding are 41.88M, and float is at 40.15M with Short Float at 7.80%. Institutions hold 89.90% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 4.59 million shares valued at $85.72 million. The investor’s holdings represent 6.466 of the KNSA Shares outstanding. As of 2024-06-30, the second largest holder is FAIRMOUNT FUNDS MANAGEMENT LLC with 3.2 million shares valued at $59.83 million to account for 4.5136 of the shares outstanding. The other top investors are HHLR ADVISORS, LTD. which holds 3.14 million shares representing 4.4287 and valued at over $58.71 million, while BAKER BROS. ADVISORS LP holds 3.9692 of the shares totaling 2.82 million with a market value of $52.62 million.
Kiniksa Pharmaceuticals International Plc (KNSA) Insider Activity
The most recent transaction is an insider sale by Ragosa Mark, the company’s CHIEF FINANCIAL OFFICER. SEC filings show that Ragosa Mark sold 15,944 shares of the company’s common stock on Mar 20 ’25 at a price of $23.11 per share for a total of $0.37 million. Following the sale, the insider now owns 23382.0 shares.
Kiniksa Pharmaceuticals International Plc disclosed in a document filed with the SEC on Mar 17 ’25 that Ragosa Mark (CHIEF FINANCIAL OFFICER) sold a total of 11,464 shares of the company’s common stock. The trade occurred on Mar 17 ’25 and was made at $23.10 per share for $0.26 million. Following the transaction, the insider now directly holds 23382.0 shares of the KNSA stock.
Still, SEC filings show that on Mar 19 ’25, Ragosa Mark (CHIEF FINANCIAL OFFICER) disposed off 8,879 shares at an average price of $23.10 for $0.21 million. The insider now directly holds 23,382 shares of Kiniksa Pharmaceuticals International Plc (KNSA).
